509 results on '"Ostrovskaya, R. U."'
Search Results
2. Effect of a Low-Molecular-Weight NGF Mimetic on a Combined High-Carbohydrate Diet/Streptozotocin-Induced Model of Type 2 Diabetes
3. Antidiabetic Effect of a New Original NT-3 Dipeptide Mimetic
4. Analysis of the Role of PI3K/Akt Pathway in the Realization of the Normalizing Effect of Low-Molecular-Weight Mimetics of NGF and BDNF on Activity of Prooxidant and Antioxidant Systems in C57BL/6 Mice with Modeled Diabetes
5. Low-Molecular-Weight Perorally Active Nerve Growth Factor Mimetic Reduces Manifestations of Diabetic Neuropathy in Wistar Rats
6. Effect of a Low-Molecular-Weight NGF Mimetic on a Combined High-Carbohydrate Diet/Streptozotocin-Induced Model of Type 2 Diabetes
7. Dose-Dependent Effect of Nerve Growth Factor Mimetic GK-2 in a Wistar Rat Diabetes Model
8. ANTIDIABETIC EFFECT OF A NEW ORIGINAL NT-3 DIPEPTIDE MIMETIC
9. The PI3K/Akt Cascade Is Involved in the Antidiabetic Effect of Compound GSB-214, a Low-Molecular-Weight BDNF Mimetic
10. Analysis of Cytoprotective Properties of Afobazole in Streptozotocin Model of Diabetes
11. Neuroprotective Dipeptide Noopept Prevents DNA Damage in Mice with Modeled Prediabetes
12. A Low Molecular Weight Nerve Growth Factor (NGF) Mimetic Given Per OS Increases the Survival of Pancreatic β-Cells in a Streptozotocin Model of Diabetes
13. Deficit of Neurotrophins in Experimental Diabetes – Correction with a Proline-Containing Dipeptide
14. Combination of a high-carbohydrate diet and streptozotoc in for modeling type 2 diabetes in Wistar rats
15. Neuroprotective Lithium Salts Protect Pancreatic β-Сells from Damage
16. Antidiabetic Activity of Afobazole in Wistar Rats
17. Drug with Neuroprotective Properties Noopept Does Not Stimulate Cell Proliferation
18. Antidiabetic Properties of Low-Molecular-Weight BDNF Mimetics Depend on the Type of Activation of Post-Receptor Signaling Pathways
19. The Influence of Noopept on Morphological, Electrophysiological, and Biochemical Changes in the Retina during the Experimental Thrombosis of Its Vessels
20. N-Phenylacetylglycyl-L-Proline Ethyl Ester Converts into Cyclo-L-Prolylglycine Showing a Similar Spectrum of Neuropsychotropic Activity
21. Glutamate excitotoxicity and oxidative stress induced by experimental thrombosis of retinal vessels
22. Noopept Normalizes Parameters of the Incretin System in Rats with Experimental Diabetes
23. Comparative Activity of Proline-Containing Dipeptide Noopept and Inhibitor of Dipeptidyl Peptidase-4 Sitagliptin in a Rat Model of Developing Diabetes
24. Nootropic Dipeptide Noopept Enhances Inhibitory Synaptic Transmission in the Hippocampus
25. Efficiency of Noopept in Streptozotocin-Induced Diabetes in Rats
26. Search for small molecules with antipsychotic activity based on neurotensin
27. Genotype-dependent characteristics of behavior in mice in cognitive tests. The effects of Noopept
28. Noopept stimulates the expression of NGF and BDNF in rat hippocampus
29. Original nootropic drug Noopept prevents memory deficit in rats with muscarinic and nicotinic receptor blockade
30. Noopept efficiency in experimental Alzheimer disease (cognitive deficiency caused by β-amyloid25–35 injection into Meynert basal nuclei of rats)
31. The effect of the synthetic neuroprotective dipeptide noopept on glutamate release from rat brain cortex slices
32. Designing nootropic dipeptides using an evolutionary-genetic approach
33. Cholinopositive Effect of Dilept (Neurotensin Peptidomimetic) as the Basis of Its Mnemotropic Effect
34. Effect of Neurotensin Peptidomimetics on Thermoregulation in Rats
35. Preclinical in vivo Neurotoxicity Studies of Drug Candidates
36. Antidiabetic activity of a novel dipeptide mimetic of nerve growth factor
37. Neuromodulatory Mechanism Underlying the Effect of the Atypical Dipeptide Neuroleptic Dilept
38. Synthesis and Antidopamine Effect of Conformation-Constrained Analogs of the Dipeptide Neuroleptic Dilept
39. Effects of Neurotensin Dipeptide Analog Dilept on Dopamine Metabolism and Synthesis in the Nucleus Accumbens of Wistar Rats
40. Proline-Containing Dipeptide GVS-111 Retains Nootropic Activity after Oral Administration
41. Fibrin-Depolymerization Activity and the Antiplatelet Effect of Small Cyclic and Linear Proline-Containing Peptides
42. Neuroprotective properties of nootropic dipeptide GVS-111 inin vitro oxygen-glucose deprivation, glutamate toxicity and oxidative stress
43. Neuroprotective Properties of Nootropic Dipeptide GVS-111 in in Vitro Oxygen-Glucose Deprivation, Glutamate Toxicity and Oxidative Stress
44. Modulation of long-term memory by delayed administration of the amide of L-pyroglutamyl-D-alanine, a nootropic agent, in spaced and massed training in rats
45. Genotype-dependent characteristics of behavior in mice in cognitive tests. The effects of Noopept
46. Dipeptide preparation Noopept prevents scopolamine-induced deficit of spatial memory in BALB/c mice
47. Noopept pharmacokinetics after intravenous administration of a lyophilized medicinal form in rats
48. Molecular design, synthesis and neuroleptic activity of dipeptide analogs of sulpride
49. Electrophysiological and neuropharmacological analysis of interaction between the systems of excitation and inhibition in the cerebral cortex
50. The major metabolite of dipeptide piracetam analogue GVS-111 in rat brain and its similarity to endogenous neuropeptide cyclo-l-prolylglycine
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.